However, the penetrance for APOE ε4/ε4 was not 100% for intermediate and high AD pathology in most age groups, despite most participants being older than 75 years and homozygotes for APOE ε4 having higher or intermediate Braak scores (Figure 2). Here, APOE is linked to Alzheimer disease.